NCT02418182

Brief Summary

Current standard of care is no pretreatment medications before the egg retrieval, and the investigators would like to evaluate if preoperative Tylenol improves procedure and post procedure pain control over the current practice (no pre-treatment). Specifically, this study will compare Tylenol with a placebo when given before retrieval procedures. The investigators believe that if Tylenol can offer better analgesic relief than no pretreatment medications, then it may reduce the amount of narcotics needed by patients during and after the procedure and contribute to better patient satisfaction. . This study will enroll 100 participants all from University of Alabama at Birmingham (UAB).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for phase_4 pain

Timeline
Completed

Started Jan 2015

Typical duration for phase_4 pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 13, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 16, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

February 18, 2020

Completed
Last Updated

February 18, 2020

Status Verified

February 1, 2020

Enrollment Period

1.5 years

First QC Date

April 13, 2015

Results QC Date

July 29, 2019

Last Update Submit

February 10, 2020

Conditions

Keywords

AnalgesicPain ControlIVFTylenolAcetaminophenEgg Retrievaliv vitro Fertilization

Outcome Measures

Primary Outcomes (2)

  • Median of Cumulative Pain Scores Up to 60 Minutes Post Procedure

    Median of cumulative pain scores (measured on a visual analog scale from 0-10 where 0=no pain and 10=worst pain) taken during the recovery period (15, 30, 45, and 60 minutes post procedure)

    60 minutes post-procedure

  • Median of Cumulative Pain Scores Up to 24 Hours Post Procedure

    Median Pain score (measured on a visual analog scale from 0-10 where 0=no pain and 10=worst pain) taken at 24-hours post-procedure

    24-hours post-procedure

Secondary Outcomes (2)

  • Number of Participants With Use of Analgesics up to 60 Minutes Post Procedure

    60-minutes post-procedure

  • Number of Participants With Use of Analgesics in the First 24 Hours After Discharge

    60-minutes post-procedure to 24-hours after procedure

Study Arms (2)

Control

PLACEBO COMPARATOR

Control group participants will receive unlabelled 2 non-active placebo tablets approximately 1 hour prior to transvaginal oocyte retrieval procedure.

Drug: placebo

Experimental

EXPERIMENTAL

Experimental group participants will receive 2 acetaminophen 500mg tablets approximately 1 hour prior to transvaginal oocyte retrieval procedure.

Drug: Acetaminophen

Interventions

Acetaminophen total dose of 1000mg

Also known as: Tylenol, paracetamol
Experimental

subjects randomized to this group will be given placebo tablets

Also known as: sugar pill
Control

Eligibility Criteria

Age21 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • English Speaking
  • Undergoing Transvaginal Oocyte Retrieval Procedure

You may not qualify if:

  • Acetaminophen allergy
  • Opioid dependency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Deidre D Gunn, MD

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Conditions

PainAgnosia

Interventions

AcetaminophenSugars

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCarbohydrates

Results Point of Contact

Title
Deidre Gunn, Assistant Professor
Organization
University of Alabama at Birmingham

Study Officials

  • Deidre D Gunn, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 13, 2015

First Posted

April 16, 2015

Study Start

January 1, 2015

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

February 18, 2020

Results First Posted

February 18, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will share

Study Protocol and Statistical Analysis Plan

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
To Be Determined
Access Criteria
Shared through CT.gov

Locations